These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine]. Scardino R; Colao G; Didonato F; Sepe V Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956 [No Abstract] [Full Text] [Related]
3. Quinidine revisited. Yang F; Hanon S; Lam P; Schweitzer P Am J Med; 2009 Apr; 122(4):317-21. PubMed ID: 19249010 [TBL] [Abstract][Full Text] [Related]
5. [Anti-arrhythmia agents]. Kaufmann G Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645 [No Abstract] [Full Text] [Related]
6. [Electrophysiological principles of the action of antiarrhythmia agents]. Sanna GP; Lomanto B; Rossi A Minerva Cardioangiol; 1974 Nov; 22(11):731-58. PubMed ID: 4453368 [No Abstract] [Full Text] [Related]
7. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'. Bozic B; Uzelac TV; Kezic A; Bajcetic M Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701 [TBL] [Abstract][Full Text] [Related]
8. The electrophysiology of Norpace (Part II). Befeler B Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398 [No Abstract] [Full Text] [Related]
9. Drug evaluation: dronedarone, a novel non-iodinated anti-arrhythmic agent. Sablayrolles S; Le Grand B Curr Opin Investig Drugs; 2006 Sep; 7(9):842-9. PubMed ID: 17002263 [TBL] [Abstract][Full Text] [Related]
10. Block of NA+ and K+ currents in rat ventricular myocytes by quinacainol and quinidine. Pugsley MK; Walker MJ; Saint DA Clin Exp Pharmacol Physiol; 2005; 32(1-2):60-5. PubMed ID: 15730436 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH; van de Loo A; Baedeker F J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608 [TBL] [Abstract][Full Text] [Related]
12. [Functional state of the heart in cardiac fibrillation before and during treatment with quinidine]. Ivanenko NA Vrach Delo; 1967; 7():64-7. PubMed ID: 5621750 [No Abstract] [Full Text] [Related]
14. [A new anti-arrhythmic agent: a prolonged-action derivative of quinidine]. Warembourg H; Ducloux G Lille Med; 1971 Jan; 16():Suppl 1:234-7. PubMed ID: 5162045 [No Abstract] [Full Text] [Related]
15. [Drug therapy of arrhythmia--its therapeutic and adverse effects]. Nohara Y Nihon Rinsho; 1968 Aug; 26(8):1884-98. PubMed ID: 4888917 [No Abstract] [Full Text] [Related]
16. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist]. Tamargo J; Valenzuela C; Delpón E Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683 [No Abstract] [Full Text] [Related]
17. The quinidine-digoxin interaction: what do we know about it? Bigger JT N Engl J Med; 1979 Oct; 301(14):779-81. PubMed ID: 481483 [No Abstract] [Full Text] [Related]
18. Quinidine rehabilitated and more lessons from the PAFAC and SOPAT anti-arrhythmic drug trials for the prevention of paroxysmal atrial fibrillation. van Hemel N Eur Heart J; 2004 Aug; 25(16):1371-3. PubMed ID: 15321693 [No Abstract] [Full Text] [Related]